TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Deal-Making Valeant Pharmaceuticals Intl Inc. Shows No Signs of Slowing Down

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) dominates the TSX’s health care group, but there are other stocks in the sector worth…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Continue its Meteoric Rise?

    Here's why I'm not so optimistic about Valeant Pharmaceuticals Intl Inc. (TSX: VRX)(NYSE: VRX).

    Read more »

    The Motley Fool
    Investing

    Why Is Warren Buffett’s Right-Hand Man so Bearish on Valeant Pharmaceuticals Intl Inc.?

    Charlie Munger does not have nice things to say about Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). But is that enough of…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Acquired Salix Pharmaceuticals Ltd.:Now What?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has finished buying another company. Could a $2 billion product be the reason to buy…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Inc. a Soaring Rocket or a Hot Air Balloon?

    Valeant Pharmaceuticals Inc. (TSX:VRX)(NYSE:VRX) has been a big win for its shareholders. Just how long can the good times last?

    Read more »

    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc. on the Salix Pharmaceuticals, Ltd. Acquisition News?

    I would hold for a dip on Valeant Pharmaceuticals Intl. Inc. (TSX:VRX)(NYSE:VRX) before buying on its recent acquisition news.

    Read more »

    Investing

    Is Valeant Pharmaceuticals Intl Inc a $250 Stock?

    Barclays analysts see Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as an overlooked growth story. Is now the time to buy?

    Read more »

    The Motley Fool
    Investing

    4 Easy Ways to Invest in This Upcoming $1.2 Trillion Opportunity

    There's a common theme of why now's a good time to buy Loblaw Companies Limited (TSX:L), Extenticare Inc. (TSX:EXE), Chartwell…

    Read more »

    Investing

    (Review) These Stocks Have Hit 52-Week Highs: Should You Buy, Sell, or Hold?

    CGI Group Inc. (TSX:GIB.A)(NYSE:GIB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have both hit 52-week highs. Here’s what to consider.

    Read more »

    Investing

    Will Pfizer Inc. Look to Buy Valeant Pharmaceuticals Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is the right size for Pfizer Inc. (NYSE:PFE), but Valeant might actually turn out to…

    Read more »

    Investing

    Invest in China With Valeant Pharmaceutical Intl Inc.

    China's middle class is growing, expanding the market for Valeant Pharmaceuticals International Inc.'s (TSX:VRX)(NYSE:VRX) products.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical International Inc. Changes Strategy; Is Now the Time to Buy?

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) is changing strategies and avoiding acquisition. Does that make it a buy?

    Read more »